Arthritis drug and remdesivir combo get emergency FDA approval

Baricitinib combined with remdesivir improved survival odds by a third for hospitalized patients on oxygen, compared to remdesivir alone - but now WHO officials say the antiviral does not work.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news